MedPath

GE HealthCare's Signa Magnus Head-Only MRI Scanner Receives FDA Clearance

• GE HealthCare's Signa Magnus, a head-only MRI scanner, has received 510(k) clearance from the U.S. Food and Drug Administration, facilitating its market entry. • The Signa Magnus system offers advanced clinical imaging and neuroscience capabilities, potentially improving the detection of various conditions affecting the head. • Existing facilities can upgrade to the new Signa Magnus system, expanding access to this technology without requiring entirely new installations.

GE HealthCare announced that its Signa Magnus head-only magnetic resonance imaging (MRI) scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance allows GE HealthCare to market and distribute the Signa Magnus system in the United States.
The Signa Magnus is designed to provide advanced clinical imaging and neuroscience capabilities. GE HealthCare suggests that the new system could aid in detecting various conditions affecting the head. The 510(k) clearance pathway is reserved for devices that are substantially equivalent to devices already legally marketed.
According to GE HealthCare, existing facilities can upgrade their current MRI systems to the Signa Magnus, potentially reducing the cost and time associated with adopting the new technology.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

SyntheticMR's SyMRI 15 Receives FDA 510(k) Clearance for Diagnostic Image Replacement

SyntheticMR's SyMRI 15 has received FDA 510(k) clearance, enabling its use for diagnostic image replacement of conventional MRI images.
The technology enhances MRI workflows by replacing conventional 3D imaging and providing tissue quantification.

AI-Powered Breast Cancer Detection Gains FDA Clearance for Expanded Mammography System Compatibility

SmartMammo Dx, an AI algorithm by DeepHealth, secured FDA clearance for use with GE HealthCare's Senographe Pristina mammography systems.
Transpara 2.1, ScreenPoint Medical's Breast AI, obtained FDA clearance for breast density assessment and temporal comparison, improving cancer detection.

Polarean Imaging Receives FDA Clearance to Expand MRI Chest Coil Compatibility

Polarean Imaging secured FDA 510k clearance for its MRI chest coil to include GE Healthcare's 3 Tesla MRI scanners, enhancing Xenon-129 nuclei visualization.
The expanded clearance ensures Polarean's Xenon MRI technology is accessible to more institutions and clinicians across the U.S. for lung disease detection.

FDA Approves Landiolol (Rapiblyk) for Rapid Heart Rate Reduction in Critical Care

The FDA has approved landiolol (Rapiblyk) for short-term treatment of supraventricular tachycardia, including atrial fibrillation and atrial flutter, in critical care settings.
Landiolol, an intravenous adrenergic receptor antagonist, demonstrated a heart rate decrease within 10 minutes in up to 90% of patients in clinical trials.

GE HealthCare's SIGNA MAGNUS Head-Only MRI System Receives FDA Clearance

GE HealthCare's SIGNA MAGNUS, a 3.0T head-only MRI, has received FDA clearance, offering advanced neuroimaging capabilities for clinical and research use.
The SIGNA MAGNUS features an innovative asymmetric gradient coil design, enhancing gradient performance and enabling high-resolution imaging with shorter scan times.

FDA Clears Gentuity's HF-OCT Imaging System for Coronary Interventions

Gentuity receives FDA 510(k) clearance for its HF-OCT imaging system with the Vis-Rx micro-imaging catheter, enhancing coronary intervention procedures.
The system is the only intravascular imaging platform indicated for pre- and post- percutaneous coronary intervention (PCI) assessment, optimizing treatment plans.

FDA Clears New PET Imaging Tools for Enhanced Alzheimer's Diagnosis and Monitoring

Siemens Healthineers' syngo.PET Cortical Analysis software gains FDA clearance for Centiloid scoring and tau PET quantification, enhancing Alzheimer's disease assessment.
Centiloid scoring standardizes amyloid plaque quantification across different PET scans, crucial for accurate diagnosis and monitoring of amyloid-targeting therapies.

GE HealthCare's MIM Software Gains FDA Clearance for Monte Carlo Dosimetry in Theranostics

GE HealthCare's MIM Software received FDA 510(k) clearance for Monte Carlo dosimetry, enhancing precision in radiopharmaceutical therapy.
The clearance enables absorbed dose calculations via the Dose Planning Method (DPM) within MIM SurePlan MRT, streamlining dosimetry workflows.

SpineGuard's PsiFGuard Receives FDA Clearance for Sacroiliac Joint Fusion

SpineGuard's PsiFGuard, a smart drilling device for posterior sacroiliac fusion (PsiF), has received FDA 510(k) clearance for commercial use in the United States.
The PsiFGuard device utilizes SpineGuard's Dynamic Surgical Guidance (DSG®) technology to enhance the accuracy of implant placement in SI joint fusion procedures.

Avicenna.AI's CINA-CSpine AI Tool Receives FDA 510(k) Clearance for Cervical Spine Fracture Detection

Avicenna.AI has received FDA 510(k) clearance for its CINA-CSpine tool, designed to detect and assess cervical spine fractures using AI.
The CINA-CSpine tool utilizes deep learning and machine learning algorithms to analyze CT imaging for cervical spine fractures.

Reference News

[1]
GE HealthCare Gets FDA Approval For Head-Only MRI Scanner | Morningstar
morningstar.com · Nov 13, 2024

GE HealthCare's head-only MRI scanner, Signa Magnus, received FDA 510(k) clearance, offering new capabilities in clinica...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy